- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition.
February 25, 2019
LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma.
February 22, 2019
Detection of circulating tumour cells and their potential use as a biomarker for advanced renal cell carcinoma.
February 22, 2019
High expression of TAZ serves as a novel prognostic biomarker and drives cancer progression in renal cancer.
February 22, 2019
TOX3 Inhibits Cancer Cell Migration and Invasion via Transcriptional Regulation of SNAI1 and SNAI2 in Clear Cell Renal Cell Carcinoma.
February 21, 2019
Essential Research Priorities in Renal Cancer: A Modified Delphi Consensus Statement.
February 21, 2019
Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.
February 21, 2019
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment.
February 19, 2019
Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma.
February 19, 2019
CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma.
February 19, 2019
Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus.
February 18, 2019
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy.
February 18, 2019